Literature DB >> 4084169

Plasma norepinephrine, blood pressure and heart rate response to graded change in body position.

V Fiorica, D C Kem.   

Abstract

In this study, 44 human subjects underwent either an orthostatic postural change (supine to stand, n = 17) or a graded change in body position (head-up) on a tilt-table (n = 27). No significant changes in systolic blood pressure or mean blood pressure were observed during either maneuver; significant increases, under both conditions, were observed in diastolic blood pressure and heart rate. Plasma norepinephrine concentrations after orthostatic position change increased significantly (supine 181 +/- 14 (S.E.M.) pg X ml-1; stand, 472 +/- 35 pg X ml-1, p less than 0.01). Plasma norepinephrine concentrations during graded postural change increased proportionately with increasing degrees of tilt (r = 0.76, p less than 0.01). A significant correlation between plasma norepinephrine and heart rate was observed during both positional change maneuvers (graded tilt-table, r = 0.80, p less than 0.01; orthostatic, r = 0.50, p less than 0.01). These results suggest that the degree of sympathetic nervous system activity for blood pressure regulation during graded postural change is appropriately reflected by plasma norepinephrine concentrations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4084169

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  3 in total

1.  Effects of plasmapheresis on short-term variability of blood pressure in healthy donors.

Authors:  A Girard; M L Phan; F Weise; J L Elghozi
Journal:  Clin Auton Res       Date:  1992-10       Impact factor: 4.435

2.  Head-up tilt table test: how far and how long?

Authors:  R K Khurana; E M Nicholas
Journal:  Clin Auton Res       Date:  1996-12       Impact factor: 4.435

3.  Epidemiology of resting pulse rate of persons ages 25-74--data from NHANES 1971-74.

Authors:  R F Gillum
Journal:  Public Health Rep       Date:  1992 Mar-Apr       Impact factor: 2.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.